EARLY EVENTS IN EPSTEIN-BARR-VIRUS GENOME EXPRESSION AFTER ACTIVATION - REGULATION BY 2ND MESSENGERS OF B-CELL ACTIVATION

被引:43
作者
MELLINGHOFF, I
DAIBATA, M
HUMPHREYS, RE
MULDER, C
TAKADA, K
SAIRENJI, T
机构
[1] UNIV MASSACHUSETTS,SCH MED,DEPT MED,WORCESTER,MA 01655
[2] UNIV MASSACHUSETTS,SCH MED,DEPT MOLEC GENET & MICROBIOL,WORCESTER,MA 01655
[3] YAMAGUCHI UNIV,DEPT VIROL & PARASITOL,UBE,YAMAGUCHI 755,JAPAN
关键词
D O I
10.1016/0042-6822(91)90574-U
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
RNA transcription from the BamHI Z and BamHI R and HindIII G regions of the Epstein-Barr virus (EBV) genome was studied after treatment of Akata cells with anti-immunoglobulin G (IgG), with second messenger agonists or antagonists to determine how latent EBV activation is regulated by B cell second messengers. Northern gel analysis demonstrated that BZLF1, BZLF1 + BRLF1, and BMLF1 + BSLF2 transcripts were induced at 2 hr and increased in concentration at 4 hr after induction with anti-IgG; transcripts from BRRF1, BaRF1, BMLFI, and BMRF1 were initiated at 4 hr; a transcript from BRRF2 appeared at 6 hr. The patterns of transcription from these genes after repeated stimulations with calcium ionophore A23187 + dioctanoylglycerol paralleled those with anti-IgG except that times of initiation were delayed by about 2 hr. Nuclear run-off assay of BZLF1 gene showed rapid increases in their transcriptions from 30 to 60 min after anti-IgG treatment. The protein kinase C antagonist, staurosporine, completely blocked the appearance of these transcripts, while 8-bromo cAMP + theophylline suppressed the transcription by about 40%. The regulation of EBV activation in Akata cells with anti-IgG or with second messenger agonists or antagonists can be explained by regulation at the level of transcription of immediate-early genes of EBV. © 1991.
引用
收藏
页码:922 / 928
页数:7
相关论文
共 38 条
[1]   EPSTEIN-BARR-VIRUS GENE-EXPRESSION IN P3HR1-SUPERINFECTED RAJI CELLS [J].
BIGGIN, M ;
BODESCOT, M ;
PERRICAUDET, M ;
FARRELL, P .
JOURNAL OF VIROLOGY, 1987, 61 (10) :3120-3132
[2]   THE EPSTEIN-BARR VIRUS (EBV) EARLY PROTEIN-EB2 IS A POSTTRANSCRIPTIONAL ACTIVATOR EXPRESSED UNDER THE CONTROL OF EBV TRANSCRIPTION FACTOR-EB1 AND FACTOR-R [J].
BUISSON, M ;
MANET, E ;
TRESCOLBIEMONT, MC ;
GRUFFAT, H ;
DURAND, B ;
SERGEANT, A .
JOURNAL OF VIROLOGY, 1989, 63 (12) :5276-5284
[3]   THE EPSTEIN-BARR-VIRUS ZTA TRANSACTIVATOR - A MEMBER OF THE BZIP FAMILY WITH UNIQUE DNA-BINDING SPECIFICITY AND A DIMERIZATION DOMAIN THAT LACKS THE CHARACTERISTIC HEPTAD LEUCINE ZIPPER MOTIF [J].
CHANG, YN ;
DONG, DLY ;
HAYWARD, GS ;
HAYWARD, SD .
JOURNAL OF VIROLOGY, 1990, 64 (07) :3358-3369
[4]   BOTH EPSTEIN-BARR-VIRUS (EBV)-ENCODED TRANS-ACTING FACTORS, EB1 AND EB2, ARE REQUIRED TO ACTIVATE TRANSCRIPTION FROM AN EBV EARLY PROMOTER [J].
CHEVALLIERGRECO, A ;
MANET, E ;
CHAVRIER, P ;
MOSNIER, C ;
DAILLIE, J ;
SERGEANT, A .
EMBO JOURNAL, 1986, 5 (12) :3243-3249
[5]   ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE [J].
CHIRGWIN, JM ;
PRZYBYLA, AE ;
MACDONALD, RJ ;
RUTTER, WJ .
BIOCHEMISTRY, 1979, 18 (24) :5294-5299
[6]   POLYMORPHIC PROTEINS ENCODED WITHIN BZLF1 OF DEFECTIVE AND STANDARD EPSTEIN-BARR VIRUSES DISRUPT LATENCY [J].
COUNTRYMAN, J ;
JENSON, H ;
SEIBL, R ;
WOLF, H ;
MILLER, G .
JOURNAL OF VIROLOGY, 1987, 61 (12) :3672-3679
[7]   ACTIVATION OF EXPRESSION OF LATENT EPSTEIN-BARR HERPESVIRUS AFTER GENE-TRANSFER WITH A SMALL CLONED SUBFRAGMENT OF HETEROGENEOUS VIRAL-DNA [J].
COUNTRYMAN, J ;
MILLER, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (12) :4085-4089
[8]  
DAIBATA M, 1990, J IMMUNOL, V144, P4788
[9]  
DAIBATA M, 1991, J IMMUNOL, V147, P292
[10]   EPSTEIN-BARR VIRUS BZLF1 TRANS-ACTIVATOR SPECIFICALLY BINDS TO A CONSENSUS AP-1 SITE AND IS RELATED TO C-FOS [J].
FARRELL, PJ ;
ROWE, DT ;
ROONEY, CM ;
KOUZARIDES, T .
EMBO JOURNAL, 1989, 8 (01) :127-132